These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7735218)

  • 41. Activation of radiosensitizers by hypoxic cells.
    Olive PL; Durand RE
    Br J Cancer Suppl; 1978 Jun; 3():124-8. PubMed ID: 354676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
    Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary evaluation of isocyanate-generating nitroheterocycles as chemosensitizers, radiosensitizers and hypoxic cell cytotoxic agents.
    Mulcahy RT; Wustrow DJ; Kende AS
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1609-13. PubMed ID: 6548210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyfunctional radiosensitizers III. Effect of the biradical (Ro-03-303) in combination with other radiosensitizers on the survival of hypoxic V-79 cells.
    Millar BC; Fielden EM; Smithen CE
    Radiat Res; 1977 Mar; 69(3):489-99. PubMed ID: 847098
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypoxic cell radiosensitizer present status and problems from viewpoint of clinical radiotherapy].
    Ono K; Sasai K; Masunaga S; Kitakabu Y; Fushiki M; Kinashi Y; Takahashi M; Abe M
    Gan No Rinsho; 1990 Oct; 36(13):2255-8. PubMed ID: 2250344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
    Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
    J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
    Arzneimittelforschung; 2012 Jan; 62(1):46-52. PubMed ID: 22331763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizers.
    Hartman GD; Hartman RD; Schwering JE; Saari WS; Engelhardt EL; Jones NR; Wardman P; Watts ME; Woodcock M
    J Med Chem; 1984 Dec; 27(12):1634-9. PubMed ID: 6389865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
    Garg PK; Garg S; Degraff WG; Zalutsky MR; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1992; 22(3):593-6. PubMed ID: 1531220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Thio-5-bromo-2'-deoxyuridine: chemical synthesis and therapeutic potential of UVA-induced DNA damage.
    Xu YZ; Zhang X; Wu HC; Massey A; Karran P
    Bioorg Med Chem Lett; 2004 Feb; 14(4):995-7. PubMed ID: 15013008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel radiation sensitizers targeting tissue hypoxia.
    Rowinsky EK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):61-70. PubMed ID: 10550828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the relative activities of 8 radiosensitizers in the SOS chromotest.
    Widdick DA; Edwards DI
    Mutat Res; 1991 Jan; 259(1):89-93. PubMed ID: 1988825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiosensitization of E. coli B/r by 9-anilinoacridines.
    Roberts PB; Denny WA; Cain BF
    Br J Cancer; 1979 Oct; 40(4):641-8. PubMed ID: 387061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
    Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
    Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain.
    Kagiya VT; Sugita T; Nishimoto S; Masuoka M; Zhou L; Abe M; Shibamoto Y; Sasai K
    Int J Radiat Oncol Biol Phys; 1992; 22(3):597-600. PubMed ID: 1735698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MGM
    Bioorg Med Chem Lett; 2018 May; 28(9):1464-1470. PubMed ID: 29628325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical modification of radiation effects.
    Phillips TL
    Cancer; 1977 Feb; 39(2 Suppl):987-98. PubMed ID: 319901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.
    Asquith JC; Watts ME; Patel K; Smithen CE; Adams GE
    Radiat Res; 1974 Oct; 60(1):108-18. PubMed ID: 10881704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.